Maravai LifeSciences Holdings Inc <MRVI.OQ> expected to post a loss of 4 cents a share - Earnings Preview
Maravai LifeSciences Holdings Inc MRVI.OQ MRVI.O is expected to show a fall in quarterly revenue when it reports results on March 7 (estimated) for the period ending December 31 2024
The San Diego California-based company is expected to report a 22.7% decrease in revenue to $57.345 million from $74.14 million a year ago, according to the mean estimate from 14 analysts, based on LSEG data.
LSEG's mean analyst estimate for Maravai LifeSciences Holdings Inc is for a loss of 4 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 7 "hold" and 1 "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Maravai LifeSciences Holdings Inc is $9.25, above its last closing price of $2.84.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Sep. 30 2024 | -0.01 | -0.01 | -0.02 | Missed | -160.1 |
Jun. 30 2024 | 0.00 | 0.00 | 0.00 | Met | -100 |
Mar. 31 2024 | -0.03 | -0.03 | -0.02 | Beat | 21.4 |
Dec. 31 2023 | -0.01 | -0.01 | 0.01 | Beat | 184.6 |
Sep. 30 2023 | 0.00 | 0.01 | -0.01 | Missed | -257.2 |
Jun. 30 2023 | 0.01 | 0.01 | 0.00 | Missed | -100 |
Mar. 31 2023 | 0.04 | 0.04 | 0.03 | Missed | -17.2 |
Dec. 31 2022 | 0.35 | 0.34 | 0.35 | Beat | 2.4 |
This summary was machine generated March 5 at 21:11 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Related Articles
[Crypto IPO] Figure Skyrockets 44% on IPO Debut, All Eyes Now on Gemini as the Next Crypto Star
Figure’s strong first-day performance sets the stage for Gemini’s highly anticipated listing.
[Reuters Breakingviews] Inflation defences are no match for debt burden
By Edward ChancellorLONDON, Sept 11 (Reuters Breakingviews) - Countries across the Western world are over-indebted. In theory, they could grow their way out of the debt or rein in their fiscal deficits. But the richer countries have a miserable recent growth record. And as the fall of French Prime M
U.S. August CPI Preview: Persistent Rise in Inflation, What Impact on Rate Cuts? And on US Stocks?
TradingKey - On 11 September 2025, the U.S. will publish August CPI data. Consensus forecasts indicate a 0.3% month-over-month increase for both headline CPI and core CPI. As a result, headline CPI year-over-year may climb to 2.9%, up from 2.7%
Fed to Cut Rates: All Asset Prices Up!
TradingKey - The Federal Reserve is almost certain to restart its interest rate cut cycle on 17 September this year. After in-depth research, we have concluded that cryptocurrencies, the broader U.S. stock market, and short-term U.S. Treasury bonds will all go up.
Unlocking Gold’s Next Leg: $4,000 in Reach by 2025？
TradingKey - Gold has kicked off a fresh uptrend in early September, breaking out of months of compression and reclaiming key territory. The decisive move above $3,500 establishes a new support base and puts higher objectives back on the table for the weeks ahead
